CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome

Published:2017-08-02 Issue:1 Volume:363 Page:35-44
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

de Wit Raymond H.,Heukers Raimond,Brink Hendrik J.,Arsova Angela,Maussang David,Cutolo Pasquale,Strubbe Beatrijs,Vischer Henry F.,Bachelerie Françoise,Smit Martine J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference61 articles.

1. Genetics on a WHIM

2. CXCL12/CXCR4-Axis Dysfunctions: Markers of the Rare Immunodeficiency Disorder WHIM Syndrome

3. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12

4. Clinical validation of a CXCR4 mutation screening assay for Waldenstrom macroglobulinemia;Ballester;Clin Lymphoma Myeloma Leuk,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WHIM Syndrome: First Reported Case in a Patient of African Ancestry;Case Reports in Hematology;2023-02-06

2. Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands;Molecules;2023-01-24

3. Identification of Biomarkers Associated With CD4+ T-Cell Infiltration With Gene Coexpression Network in Dermatomyositis;Frontiers in Immunology;2022-05-30

4. Detection of genome‐edited and endogenously expressed G protein‐coupled receptors;The FEBS Journal;2021-02-09

5. Nanobodies in cancer;Seminars in Immunology;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP